Inventor · disambiguated record
Kumar Balashanmuga Pabbisetty
Also filed as: PABBISETTY KUMAR B · PABBISETTY KUMAR BALASHANMUGA
13 granted patents·7 pending applications·23 citations·filing 2013–2022
86Inventor score
Files withBRISTOL MYERS SQUIBB CO20
Top patents by PatentIndex Score
20 records- 0196US9453018B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·13 cites·17 claims
- 0287US11053247B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 6, 2021·2 cites·9 claims
- 0386US10336754B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 2, 2019·2 cites·17 claims
- 0478US9777001B2Macrocycles with aromatic P2′ groups as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 3, 2017·3 cites·11 claims
- 0577US12428421B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 30, 2025·0 cites·31 claims
- 0674US9409908B2Dihydropyridone p1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 9, 2016·1 cites·14 claims
- 0773US10611776B2Spiroheptane salicylamides and related compounds as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 7, 2020·1 cites·17 claims
- 0870US9920075B2Triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidaseBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 20, 2018·1 cites·9 claims
- 0961US2016368923A1Pyrimidinones as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 1060US2024417369A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1159US10273236B2Macrocyclic factor XIa inhibitors bearing heterocyclic groupsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 30, 2019·0 cites·11 claims
- 1258US10829501B2Spiroheptane salicylamides and related compounds as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 10, 2020·0 cites·5 claims
- 1358US2025011288A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1458US2025221966A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1557US2025268903A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1654US9951071B2Dihydropyridone P1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 24, 2018·0 cites·7 claims
- 1754US2017342071A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 1846US2017057961A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1938US10287288B2Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moietiesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 14, 2019·0 cites·11 claims
- 2037US10316035B2Triazolopyridine inhibitors of myeloperoxidaseBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 11, 2019·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Kumar Balashanmuga Pabbisetty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →